Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-24 @ 11:07 PM
NCT ID:
NCT01619969
Eligibility Criteria:
Main Inclusion Criteria:
* Fever of ≥ 38°C of ≤ 48 hr duration.
* At least two of the following criteria indicating probable dengue infection:
* Live or work in or recent travel to dengue endemic area
* Nausea and vomiting
* Presence of rash
* Aches and pains, including headache, or retro-orbital, muscle or joint pain
* Positive NS1 strip assay
Main Exclusion Criteria:
* Clinical signs and symptoms for severe dengue
* Patients with certain abnormal laboratory values
* History of presently active intestinal disorders
* Severe diarrhea
* Current usage of anticoagulant drugs
* Other clinically significant acute illness
* History of severe drug and/or food allergies
* Exposure to investigational agent within 30 days prior to study drug administration
* Clinically significant abnormal physical exam unrelated to dengue fever
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
60 Years
Study:
NCT01619969
Study Brief:
Protocol Section:
NCT01619969